Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased activity.
Articles
Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021
Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market projected to reach $135 billion by 2021.
Marijuana Company of America (MCOA) Delivers Distinctive Cannabis Investment Opportunities
Marijuana Company of America (OTC: MCOA) is a distinctive corporation utilizing a strategic business structure within this burgeoning industry.
Biotech M&A Momentum Attractive for Cannabinoid R&D Space
With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.
Biotechs Develop Proprietary Systems to Drive CBD Research and Development
With a market that’s expected to grow from $2 billion in 2020 to $50 billion in only nine years, according to Statista, biotechnology companies are increasingly focused on the development of proprietary systems and procedures to drive research and production of cannabinoid pharmaceuticals.
How Biosynthesis is Revolutionizing Cannabinoid Pharmaceuticals
Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
Medical Cannabis Payment Solutions (REFG) Offers Cannabis Retailers Merchant Processing They Can Bank On
Through its wholly owned subsidiary, StateSourced, the company provides a proprietary, closed loop system of merchant processing for marijuana enterprises.
Why Medical Cannabis Payment Solutions (REFG) is “One to Watch”
Medical Cannabis Payment Solutions is intent on opening the bottleneck with its proprietary merchant processing system designed to serve the monetary demands of the state-legalized cannabis market.
Cannabis Demand in Canada Creates Considerable Opportunity for ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)
As Canada prepares for the legalization of recreational marijuana in July 2018, analysts are noting a shortage of supplies compared to expected demand for cannabis products.
Skinvisible, Inc.’s (SKVI) Topical Drug Delivery System Set to Enjoy New Licensing Opportunities
Skinvisible, Inc. (OTCQB: SKVI) is set for a business renaissance in the coming years.
Leaders in Medical Marijuana and the Global Alzheimer’s Markets
Investors interested in medicinal marijuana and/or Alzheimer’s treatments will find themselves looking at a global landscape of key players.
Marijuana Company of America, Inc. (MCOA) Building Momentum as Legalization Push Gains Steam
Marijuana Company of America, Inc. (OTC: MCOA) is building upon its vertically integrated business strategy by taking a unique approach to how companies within the industry position themselves in the marketplace.
AppSwarm, Inc. (SWRM) Leverages Technology and Business Expertise to Enter the Cannabis Market Through SinglePoint, Inc. (SING) Joint Venture
AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING).
Strategic Acquisition Enables Grey Cloak Tech, Inc.’s (GRCK) Development in Two Industries
On October 24, 2017, Grey Cloak Tech, Inc. announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products.
Innovative Biotechnology Companies are Transforming Cannabis-based Medical Products
These forward-thinking companies are developing proprietary systems and delivery methods to drive their research and development programs for a leading position in industry breakthroughs.